Goldman Sachs’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-40,000
| Closed | -$353K | – | 6895 |
|
|
2022
Q1 | $353K | Hold |
40,000
| – | – | ﹤0.01% | 5567 |
|
|
2021
Q4 | $277K | Buy |
40,000
+21,700
| +119% | +$318K | ﹤0.01% | 5710 |
|
|
2021
Q3 | $227K | Buy |
+18,300
| New | +$264K | ﹤0.01% | 5668 |
|
|
2018
Q3 | – | Sell |
-48,100
| Closed | -$1.42M | – | 5875 |
|
|
2018
Q2 | $1.42M | Buy |
48,100
+47,000
| +4,273% | +$1.49M | ﹤0.01% | 3851 |
|
|
2018
Q1 | $40K | Sell |
1,100
-52,900
| -98% | -$1.91M | ﹤0.01% | 5537 |
|
|
2017
Q4 | $1.72M | Sell |
54,000
-53,600
| -50% | -$1.68M | ﹤0.01% | 3908 |
|
|
2017
Q3 | $4.15M | Buy |
107,600
+72,900
| +210% | +$2.86M | ﹤0.01% | 3332 |
|
|
2017
Q2 | $1.57M | Sell |
34,700
-72,800
| -68% | -$2.78M | ﹤0.01% | 4032 |
|
|
2017
Q1 | $4.16M | Buy |
107,500
+54,400
| +102% | +$2.28M | ﹤0.01% | 3099 |
|
|
2016
Q4 | $2.02M | Buy |
53,100
+43,400
| +447% | +$2.07M | ﹤0.01% | 3852 |
|
|
2016
Q3 | $525K | Sell |
9,700
-22,100
| -69% | -$1.12M | ﹤0.01% | 4997 |
|
|
2016
Q2 | $1.17M | Buy |
31,800
+7,900
| +33% | +$279K | ﹤0.01% | 4063 |
|
|
2016
Q1 | $751K | Sell |
23,900
-76,300
| -76% | -$2.64M | ﹤0.01% | 4338 |
|
|
2015
Q4 | $6.17M | Buy |
100,200
+50,200
| +100% | +$3.17M | ﹤0.01% | 2643 |
|
|
2015
Q3 | $3.47M | Buy |
+50,000
| New | +$3.47M | ﹤0.01% | 3225 |
|
Other funds holding RDUS
Goldman Sachs's RDUS Position: Q3 2022 in Review
Goldman Sachs sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 501,164 shares — an estimated $5.2M sold.
Goldman Sachs first reported a position in RDUS in Q3 2014 and held it in 32 quarters. The position peaked at $26.7M in Q4 2015. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- Goldman Sachs reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- Goldman Sachs sold 501,164 Radius Health, Inc. shares in Q3 2022, an estimated $5.2M.
- Goldman Sachs first reported a position in Radius Health, Inc. in Q3 2014 and held it in 32 quarters.
- Goldman Sachs's Radius Health, Inc. position peaked at $26.7M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.